SCHEMBL4243744

SCHEMBL4243744

CCC(CO)Nc1nc(Nc2cccc(S(=O)(=O)NCc3cccs3)c2)ncc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 9/20 0.44
▸ KDR P35968 9/20 0.44
▸ CDK2 P24941 9/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CDK4 P11802 2/20 0.44
▸ CDK7 P50613 2/20 0.44
▸ CDK9 P50750 2/20 0.44
▸ CCNT1 O60563 1/20 0.44
▸ CCND1 P24385 1/20 0.44
▸ CCNH P51946 1/20 0.44
▸ BRD4 O60885 2/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCNE1 P24864 2/20 0.43
▸ JAK2 O60674 2/20 0.40
▸ JAK3 P52333 2/20 0.40
▸ PDPK1 O15530 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ PDE5A O76074 1/20 0.40
▸ CDC7 O00311 1/20 0.40
▸ PLK4 O00444 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4063693 1.00 CDK1 (0.44) CDK1KDRCDK2CA2CDK4
SCHEMBL4068949 0.91 CDK1 (0.52) CDK1KDRCDK2CA2CDK4
SCHEMBL4060085 0.90 CDK1 (0.56) CDK1KDRCDK2CA2CDK4
SCHEMBL4067380 0.88 KDR (0.43) CDK1KDRCDK2CA2CDK4
SCHEMBL4060679 0.87 CDK1 (0.45) CDK1KDRCDK2CA2CDK4
SCHEMBL4061492 0.86 ALDH1A1 (0.44) CDK1KDRCDK2CA2CDK4
SCHEMBL4061041 0.85 CDK1 (0.45) CDK1KDRCDK2CA2CDK4
SCHEMBL4063707 0.85 CDK1 (0.43) CDK1KDRCDK2CA2CDK4
SCHEMBL4060305 0.85 CDK1 (0.45) CDK1KDRCDK2CA2CDK4
SCHEMBL4066529 0.85 CDK2 (0.45) CDK1KDRCDK2CA2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP disclosed
Send feedback